title: Acute pulmonary edema associated with ocular metipranolol use.
abstract: OBJECTIVE
  To report a case of pulmonary edema associated with the use of ocular metipranolol, a nonselective beta-blocker.
  
  
  METHODS
  A 72-year-old woman with no history of pulmonary or cardiac disease presented to the emergency room with signs and symptoms consistent with cardiogenic pulmonary edema. The patient had used metipranolol eyedrops approximately 1 hour before becoming symptomatic. When rechallenged inadvertently while hospitalized, the patient again became symptomatic. The patient's metipranolol eyedrops then were substituted with betaxolol eyedrops. She continued to be free of symptoms of pulmonary edema at subsequent clinic visits 1, 4, and 6 weeks following discharge.
  
  
  CONCLUSIONS
  This is the first reported case of pulmonary edema associated with metipranolol. There was a reasonable temporal association between use of the eyedrops and the onset of symptoms. Beta-blockers may cause cardiogenic pulmonary edema secondary to their negative inotropic and negative chronotropic effects. The drug's lipid solubility or a deficiency in the enzyme responsible for its metabolism may have allowed the drug to accumulate to a critical concentration over the 6-week period of use.
  
  
  CONCLUSIONS
  Ocular beta-blockers must be used with caution in patients with relative contraindications to beta-blockade. This case illustrates that these agents must be used prudently even in patients with no history of symptomatic congestive heart failure.
authors.affiliation: Robert C. Byrd Health Sciences Center, School of Pharmacy, West Virginia University, Morgantown 26506, USA.
authors.forename: M D
authors.initials: MD
authors.lastname: Johns
authors.forename: C D
authors.initials: CD
authors.lastname: Ponte
mesh_terms: D000368:Aged; D015784:Betaxolol / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D014290:Metipranolol / Q000009:adverse effects* / Q000627:therapeutic use; D009883:Ophthalmic Solutions; D011654:Pulmonary Edema / Q000139:chemically induced*
chemical_list: D009883:Ophthalmic Solutions; D015784:Betaxolol; D014290:Metipranolol